Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

The five-year, 150-person, phase 2 trial is investigating whether repeat BCG vaccination can clinically improve type 1 diabetes in adults with existing disease and is almost fully enrolled.

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

Puducherry has emerged as a frontrunner in Tuberculosis (TB) testing, ramping up examinations of presumptive TB patients from 2,233 per lakh population in 2015 to 2,526 per lakh in 2024, officials ...

A Bill that proposed naming Ireland's new children's hospital after Dr. Kathleen Lynn from Killala, County Mayo, was ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

Nagpur:  The “Conquer HPV & Cancer Conclave 2025” was launched today in Nagpur as part of a nationwide public health ...

The Ministry of Health is set to conduct a nationwide mass vaccination campaign against measles and typhoid, following ...

The UK’s Labour Government has revealed its ’10-Year Health Plan’ for the country’s National Health Service (NHS). Speaking at a community health centre in London, Health Secretary Wes Streeting ...

The study explores the ways in which our immune system is a major player in the pathogenesis of Alzheimer’s, and how the BCG vaccine may serve as an effective preventative treatment to this ...

Veteran consultant and former KPMG leader Pradeep Udhas reflects on his journey across tech, consulting, private equity, ...